Devices and methods for treating medical disorders with evoked potentials and vagus nerve stimulation
Devices, systems and methods for treating medical disorders, such as migraine or other primary headaches, or fibromyalgia, by noninvasive electrical stimulation of a vagus nerve, used in conjunction with the measurement of evoked potentials (EPs). The system comprises a stimulator that is applied to the surface of the patient's neck to apply electrical impulses sufficient to stimulate a cervical vagus nerve, scalp electrodes that are used to measure EPs that are evoked by that stimulation, feedback or biofeedback circuits to vary the stimulation based upon EP characteristics, and other sensory stimulation modalities that produce EPs. The system is preferably used to optimize the placement of the stimulator, to test whether a patient is a suitable candidate for treatment using vagus nerve stimulation, and to select the stimulation parameters that optimized acute or chronic treatment, e.g., by correcting an EP habituation deficit.
1. A method for determining whether a patient is a responder to a medical therapy, the method comprising:
applying a sensory stimulus to a patient;
measuring a first baseline evoked potential from the patient, wherein the first baseline evoked potential is evoked by the sensory stimulus;
applying a treatment for the medical condition to the patient;
comparing a result of the treatment to a characteristic of the first baseline evoked potential to determine whether the patient is a responder to the treatment;
measuring a second evoked potential from the patient subsequent to the treatment; and
comparing a characteristic of the first baseline evoked potential and a characteristic of the second evoked potential to determine whether the patient is a responder to the treatment, wherein the treatment increases a habituation of the second evoked potential.
2. The method of claim 1 wherein the stimulus comprises a visual, auditory, somatosensory, painful, olfactory, gustatory, vestibular, or interoceptive stimulus.
3. The method of claim 1 wherein the treatment comprises vagus nerve stimulation.
4. The method of claim 1 wherein the treatment comprises applying one or more electrical impulses transcutaneously through an outer skin surface of a neck of the patient to a vagus nerve of the patient.
5. The method of claim 1 wherein the patient exhibits a deficit with regard to habituation of the evoked potential.
6. A method for determining whether a patient is a responder to a medical therapy, the method comprising:
applying a sensory stimulus to a patient;
measuring a first baseline evoked potential from the patient, wherein the first baseline evoked potential is evoked by the sensory stimulus;
applying a treatment for the medical condition to the patient, wherein the treatment comprises a vagus nerve stimulation via a device;
comparing a result of the treatment to a characteristic of the first baseline evoked potential to determine whether the patient is a responder to the treatment;
measuring a second evoked potential from the patient subsequent to the treatment; and
comparing a characteristic of the first baseline evoked potential and a characteristic of the second evoked potential to determine whether the patient is a responder to the treatment, wherein the treatment increases a habituation of the second evoked potential.
7. The method of claim 6 , wherein the sensory stimulus comprises at least one of a visual, auditory, somatosensory, painful, olfactory, gustatory, vestibular, or interoceptive stimulus.
8. The method of claim 6 , wherein the treatment comprises an application of an electrical impulse transcutaneously through an outer skin surface of a neck of the patient to a vagus nerve of the patient.
9. The method of claim 6 , wherein the patient exhibits a deficit with regard to a habituation of the evoked potential.
10. A method for determining whether a patient is a responder to a medical therapy, the method comprising:
applying a sensory stimulus to a patient;
measuring a first baseline evoked potential from the patient, wherein the first baseline evoked potential is evoked by the sensory stimulus;
applying a treatment for the medical condition to the patient, wherein the treatment comprises an application of an electrical impulse transcutaneously via a device through an outer skin surface of a neck of the patient to a vagus nerve of the patient;
comparing a result of the treatment to a characteristic of the first baseline evoked potential to determine whether the patient is a responder to the treatment;
measuring a second evoked potential from the patient subsequent to the treatment; and
comparing a characteristic of the first baseline evoked potential and a characteristic of the second evoked potential to determine whether the patient is a responder to the treatment, wherein the treatment increases a habituation of the second evoked potential.
11. The method of claim 10 , wherein the sensory stimulus comprises at least one of a visual, auditory, somatosensory, painful, olfactory, gustatory, vestibular, or interoceptive stimulus.
12. The method of claim 10 , wherein the treatment comprises a vagus nerve stimulation.
13. The method of claim 10 , wherein the patient exhibits a deficit with regard to a habituation of the evoked potential.